Listen Now

Topics Covered

  • Overview & Definition of Biosimilars
  • The Difference Between Biosimilars & Generic Drugs
  • How Biosimilars Work & Their Use
  • Examples of Biosimilars
  • Implications in Managing the Cost of Cancer Treatments
  • Clinical Trials: How Biosimilar Research Contributes to Treatment Options
  • The Benefits of Biosimilars
  • Current Use in the Care of People Living with Cancer
  • Manufacturing & Safety Issues
  • Key Questions to Ask Your Health Care Team About Biosimilars
  • Current & Future Perspectives
  • Questions for Our Panel of Experts

Our Panel of Experts

Richard J. Gralla, MD, FACP

Professor of Medicine, Albert Einstein College of Medicine, Jacobi Medical Center

Jeffrey Crawford, MD

George Barth Geller Professor for Research in Cancer, Department of Medicine, Duke University School of Medicine, Co-Director, Solid Tumor Therapeutics Program, Duke Cancer Institute

Edward Li, PharmD, MPH, BCOP

Professor, University of New England College of Pharmacy

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare


You can download the brochure for this workshop(pdf)(79 KB)

Workshop Date

This workshop was originally recorded on May 24, 2018.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.